A Post-Earnings Sell-Off Could Be an Incredible Buying Opportunity for This Stock

Zscaler's stock fell 32% after management guided to just 16% to 17% annualized recurring revenue growth in 2027, well below prior expectations. The company said comparable ARR growth would have been 14% last quarter excluding Red Canary renewals, while usage-based pricing is gaining traction and accounted for over 30% of new annualized contract value. The article argues AI agents could eventually reaccelerate growth, but investors must first absorb a major business-model transition and acquisition-driven growth mix.

Analysis

The market is treating this as a simple growth miss, but the deeper issue is the denominator shift: usage-based monetization can create a period where reported growth slows even as underlying workload growth accelerates. That usually matters most when a software name is still owned for duration rather than current cash flow, because the multiple compresses first and the evidence of monetization improves later. In other words, this is less a fundamental deterioration than a sequencing problem — but the market rarely pays up for sequencing risk.

The second-order winner is any security vendor that can attach pricing to compute, traffic, or policy events rather than humans. Agentic AI should make seat-based models increasingly brittle across the broader software stack, not just here, because a small number of users can now generate enterprise-scale activity. That creates a subtle pressure on peers to re-bundle, re-price, or hide pricing changes inside product consolidation, which can temporarily inflate headline ARR while degrading deal quality.

For the stock itself, the key catalyst is not the next quarter but the first proof that non-seat-based ACV can offset the churn created by the transition. If that mix keeps rising, the multiple can re-rate before revenue reaccelerates; if not, the stock may stay range-bound for 2-3 quarters as investors wait for clarity on whether management is buying growth or creating a durable pricing layer. The risk case is that usage pricing expands less than expected because customers optimize traffic or centralize security spend, which would make the current valuation look less cheap than it appears.

Key Decisions for Investors

• Long ZS on weakness, but only as a staged entry over 2-3 weeks; target a 12-18 month hold if non-seat-based ACV continues compounding, with downside capped by a post-event valuation reset rather than a thesis break.
• Pair trade: long ZS / short a seat-usage-exposed software basket over 3-6 months, betting that AI-era pricing power is better rewarded in names that can monetize activity growth rather than headcount growth.
• Sell upside calls against an existing ZS long into any post-earnings relief rally; the stock likely needs multiple quarters of proof before the market pays for the 2027 acceleration story.
• Watch competitor names with weaker platform consolidation narratives; if ZS’s usage-based pricing is validated, expect relative underperformance in vendors still reliant on per-seat expansion over the next 1-2 reporting cycles.
• Do not chase the move in the next 1-2 weeks; the cleaner entry is after the market digests whether Red Canary/Symmetry are additive to net retention or just masking deceleration.